previous Page5 of 8next Page
Financial Statements
Financial Statements

Bayer Group Consolidated Statements of Cash Flows

3rd
Quarter
2008
3rd
Quarter
2009
First Nine Months
2008
First Nine Months
2009
 € million€ million€ million€ million
Income from continuing operations after taxes2752491,6181,203
Income taxes133135701549
Non-operating result276262813888
Income taxes paid or accrued(197)(131)(913)(696)
Depreciation and amortization6506802,0312,056
Change in pension provisions(5)(24)(185)(238)
(Gains) losses on retirements of noncurrent assets(12)1(78)(133)
Non-cash effects of the remeasurement of acquired assets (inventory work-down) 510 1570
Gross cash flow1,1711,1724,1443,629
     
Decrease (increase) in inventories(299)(48)(563)327
Decrease (increase) in trade accounts receivable377427(697)(371)
(Decrease) increase in trade accounts payable(78)132(143)(259)
Changes in other working capital, other non-cash items63(166)(90)283
     
Net cash provided by (used in) operating activities (net cash flow),
continuing operations

1,234

1,517

2,651

3,609
Net cash provided by (used in) operating activities (net cash flow),
discontinued operations

0

0

0

0
Net cash provided by (used in) operating activities (net cash flow) (total)1,2341,5172,6513,609
     
Cash outflows for additions to property, plant, equipment and intangible assets (492)(420)(1,127)(1,080)
Cash inflows from sales of property, plant, equipment and other assets412414847
Cash inflows from (outflows for) divestitures(3)6(52)57
Cash inflows from (outflows for) noncurrent financial assets253273116
Cash outflows for acquisitions less acquired cash(367)(6)(919)(48)
Interest and dividends received126120424435
Cash inflows from (outflows for) current financial assets361(1)
Net cash provided by (used in) investing activities (total)(667)(238)(1,452)(474)
     
Capital contributions0000
Dividend payments and withholding tax on dividends(2)0(1,042)(973)
Issuances of debt103971,1022,649
Retirements of debt(166)(346)(465)(3,224)
Interest paid(267)(259)(1,023)(1,078)
Net cash provided by (used in) financing activities (total)(332)(508)(1,428)(2,626)
     
Change in cash and cash equivalents due to business activities (total)235771(229)509
     
Cash and cash equivalents at beginning of period2,0581,8342,5312,094
     
Change in cash and cash equivalents due to changes in scope of consolidation0023
Change in cash and cash equivalents due to exchange rate movements(12)(10)(23)(11)
     
Cash and cash equivalents at end of period2,2812,5952,2812,595
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
Print page
Search
Search
Advanced Search
Download Center
 
 
 
Links
Annual Report 2008
 
Sustainable Development Report 2008
 
Financial Reports
 
Comparison
Services
Order print version
 
Event Reminder
 
Press Newsletter
 
Would you like to be kept informed about new financial reports from Bayer?
 
SMS Service
 
Notes on our information package and all services
Calendar
Tuesday, October 27, 2009
Investor Conference Call
News Conference Call